Central Venous Catheter Techniques for Shock
Trial Summary
What is the purpose of this trial?
Two different techniques for placing a central venous catheter will be compared. The studyu team hypothesizes that clinicians randomized to the peripheral catheter technique will have higher first attempt success rates, fewer procedural complications, and a shorter mean time to procedure completion than physicians assigned to wire through hollow bore needle.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it mentions that patients using aspirin or other anti-platelet medications are not excluded.
What data supports the effectiveness of the treatment Central venous catheter insertion for shock?
Central venous catheter placement is a crucial procedure in emergency medicine for administering fluids and medications, and it is frequently used in critical care settings. It is considered effective for providing vascular access in patients with chronic conditions, such as renal failure, and is essential for monitoring and treatment in various medical situations.12345
Is central venous catheter insertion generally safe for humans?
How is central venous catheter insertion unique compared to other treatments for shock?
Central venous catheter insertion is unique because it involves placing a tube directly into a large vein near the heart to deliver medications or fluids quickly and monitor heart function, which is crucial in emergency situations like shock. Unlike other treatments, it uses ultrasound guidance to ensure accurate placement and reduce complications, making it a precise and effective method for managing severe conditions.45101112
Research Team
Benjamin W Friedman, MD
Principal Investigator
Montefiore Medical Center
Eligibility Criteria
This trial is for adult patients in the emergency department who need a central venous catheter placed using ultrasound guidance. People with existing catheters that could interfere, blood clotting issues, low platelet counts, previous central lines at the same site, or conditions affecting consent are not eligible.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo central venous catheter insertion using either the standard hollow bore needle technique or the peripheral IV catheter technique
Follow-up
Participants are monitored for procedure-related adverse events and success rates
Treatment Details
Interventions
- Central venous catheter insertion
Central venous catheter insertion is already approved in European Union, United States, Canada, Japan, China, Switzerland for the following indications:
- Administration of vesicant or irritant medications
- Vasopressors
- Chemotherapy
- Total parenteral nutrition
- Poor peripheral IV access
- Renal replacement therapy
- Plasmapheresis
- Apheresis
- Transvenous pacing
- Mixed venous O2 monitoring
- CVP monitoring
- Administration of vesicant or irritant medications
- Vasopressors
- Chemotherapy
- Total parenteral nutrition
- Poor peripheral IV access
- Renal replacement therapy
- Plasmapheresis
- Apheresis
- Transvenous pacing
- Mixed venous O2 monitoring
- CVP monitoring
- Administration of vesicant or irritant medications
- Vasopressors
- Chemotherapy
- Total parenteral nutrition
- Poor peripheral IV access
- Renal replacement therapy
- Plasmapheresis
- Apheresis
- Transvenous pacing
- Mixed venous O2 monitoring
- CVP monitoring
- Administration of vesicant or irritant medications
- Vasopressors
- Chemotherapy
- Total parenteral nutrition
- Poor peripheral IV access
- Renal replacement therapy
- Plasmapheresis
- Apheresis
- Transvenous pacing
- Mixed venous O2 monitoring
- CVP monitoring
- Administration of vesicant or irritant medications
- Vasopressors
- Chemotherapy
- Total parenteral nutrition
- Poor peripheral IV access
- Renal replacement therapy
- Plasmapheresis
- Apheresis
- Transvenous pacing
- Mixed venous O2 monitoring
- CVP monitoring
- Administration of vesicant or irritant medications
- Vasopressors
- Chemotherapy
- Total parenteral nutrition
- Poor peripheral IV access
- Renal replacement therapy
- Plasmapheresis
- Apheresis
- Transvenous pacing
- Mixed venous O2 monitoring
- CVP monitoring
Find a Clinic Near You
Who Is Running the Clinical Trial?
Montefiore Medical Center
Lead Sponsor